Combination of catechin, epicatechin, and rutin : Optimization of a novel complete antidiabetic formulation using a mixture design approach

Show full item record



Permalink

http://hdl.handle.net/10138/340844

Citation

Mechchate , H , Es-safi , I , Haddad , H , Bekkari , H , Grafov , A & Bousta , D 2021 , ' Combination of catechin, epicatechin, and rutin : Optimization of a novel complete antidiabetic formulation using a mixture design approach ' , Journal of Nutritional Biochemistry , vol. 88 , 108520 , pp. 1-8 . https://doi.org/10.1016/j.jnutbio.2020.108520

Title: Combination of catechin, epicatechin, and rutin : Optimization of a novel complete antidiabetic formulation using a mixture design approach
Author: Mechchate, Hamza; Es-safi, Imane; Haddad, Hassan; Bekkari, Hicham; Grafov, Andriy; Bousta, Dalila
Contributor organization: Department of Chemistry
Date: 2021-02
Language: eng
Number of pages: 8
Belongs to series: Journal of Nutritional Biochemistry
ISSN: 0955-2863
DOI: https://doi.org/10.1016/j.jnutbio.2020.108520
URI: http://hdl.handle.net/10138/340844
Abstract: Nowadays, synthetic chemical antidiabetic drugs, besides their therapeutic effects, present adverse effects that could be hard to handle over time. In the last decade, studies reported new alternative molecules with more health benefits and less adverse effects. The goal of this study is to optimize a new antidiabetic formulation using plant flavonoids: Catechin, Epicatechin, and Rutin. They are also a powerful antioxidant and anti-inflammatory molecules. A mixture design experiment will optimize their combination to obtain a new, safe multi-targets antidiabetic formulation making it a powerful combination for the management of diabetes and its complications. To study the variation of blood glucose level in response to the treatment over the time we performed an Oral Glucose Tolerance Test. The blood glucose level variations recorded as responses for the mixture design experiment. We used the molecules at a dose of 10 mg/kg. According to the software analysis, the prediction profiler showed us the optimum combination, and the result was a binary combination between Rutin and Epicatechin (25% and 75%, respectively). This combination prevented hyperglycemia and hypoglycemia, along with the best area under the curve, and after that, we validated it through a repeated oral administration on alloxan-induced diabetic mice for 28 d. Rutin, Catechin, and Epicatechin exhibit a potent antihyperglycemic activity, their synergistic combination validates a new formulation that could be a real candidate to conventional drugs. (C) 2020 Elsevier Inc. All rights reserved.
Subject: Catechin
Diabetes
Epicatechin
Mixture design experiment
Rutin
Simplex-centroid design
1182 Biochemistry, cell and molecular biology
Peer reviewed: Yes
Rights: cc_by_nc_nd
Usage restriction: openAccess
Self-archived version: acceptedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
10.1016_j.jnutbio.2020.108520.pdf 1.225Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record